OMG, so ABBV is out here acting like they’re the hero of Canada or something. SKYRIZI® just got a big “yes, please” from Canada’s drug people for ulcerative colitis AND Crohn’s disease. Like, two big thumbs up in a row. What even? I can’t with how they’re flexing all their clinical trials — MOTIVATE, ADVANCE, FORTIFY, INSPIRE, COMMAND — it’s like a soap opera of drug tests. I swear, if their pill was a person, it’d be that overachiever ex who posts inspirational quotes but also ghosts you.
Also, ABBV just scribbled a letter of intent with the pan-Canadian Pharmaceutical Alliance. Ugh, sounds so fancy. Basically, ABBV’s saying, “Hey, Canada, let’s make this work.” But like, can we trust it? It’s all very official, way too clean compared to the drama ABBV usually serves. This isn’t some impulsive fling — it’s that serious “let’s see where this goes” with a side of paperwork.
And honestly, this healthcare sector is a whole mood. Everyone chasing approval like they’re at a party, trying to get noticed by the coolest drug agencies. ABBV’s playing it all smooth and strategic, like the ex who suddenly turns into Mr. Responsible and you’re just sitting there wondering, “Wait, when did you learn to be this boring?”
I’m just here wondering if this means SKYRIZI® is gonna become the new popular kid on the block. Because if it does, ABBV’s about to cash in big time. Like watching your ex suddenly glow up and have the whole school obsessed. But watch out — this is healthcare, so there’s always some twist coming. Maybe another trial drama, or a new competitor crashing the party.
If you wanna see how ABBV’s playing it cool while making moves, check out this Market Roast utility. I’m telling you, it’s like watching a soap but with pills, papers, and power plays.
Think you’re wired for chaos? Tap here.